 xxxd2084xxx , a fully humanized monoclonal antibody against the  xxxg807xxx  alpha, for the potential treatment of epithelial ovarian cancer.  morphotek inc is developing  xxxd2084xxx , a humanized monoclonal antibody directed against  xxxg807xxx  alpha, for the potential treatment of ovarian cancer. phase ii clinical trialsof  xxxd2084xxx , either alone or in combination with platinum/taxane chemotherapy, are underway in ovarian cancer patients experiencing their first disease recurrence.